Showing results (1261-1270 of 1,297) with videos related to

Sort By:
Pageof 130
JCO Global Oncology|May 25, 2023
QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain ReactionAnne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
Environmental Research|August 27, 2017
Occupation and mammographic density: A population-based study (DDM-Occup)Javier García-Pérez, Marina Pollán, Beatriz Pérez-Gómez, et al.
Journal of the International Society of Sports Nutrition|May 14, 2020
The athletic gut microbiotaAlex E Mohr, Ralf Jäger, Katie C Carpenter, et al.
Journal of the International Society of Sports Nutrition|December 23, 2019
International Society of Sports Nutrition Position Stand: ProbioticsRalf Jäger, Alex E Mohr, Katie C Carpenter, et al.
Annals of the Rheumatic Diseases|June 26, 2015
Recommendations for the management of autoinflammatory diseasesNienke M ter Haar, Marlen Oswald, Jerold Jeyaratnam, et al.
Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practiceC B Westphalen, L Boscolo Bielo, P Aftimos, et al.
Nature|January 11, 2023
γδ T cells are effectors of immunotherapy in cancers with HLA class I defectsNatasja L de Vries, Joris van de Haar, Vivien Veninga, et al.
The Lancet. Neurology|May 14, 2022
Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention studyLisanne M Baak, Nienke Wagenaar, Niek E van der Aa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Pageof 130